Literature DB >> 33705209

Next-Generation Endocrine Therapies for Breast Cancer.

Donald P McDonnell1, Suzanne E Wardell1, Ching-Yi Chang1, John D Norris1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33705209      PMCID： PMC8274744          DOI： 10.1200/JCO.20.03565

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  57 in total

Review 1.  Transcriptional regulation by steroid receptor coactivator phosphorylation.

Authors:  Ray-Chang Wu; Carolyn L Smith; Bert W O'Malley
Journal:  Endocr Rev       Date:  2005-04-06       Impact factor: 19.871

2.  Comparative analyses of mechanistic differences among antiestrogens.

Authors:  A L Wijayaratne; S C Nagel; L A Paige; D J Christensen; J D Norris; D M Fowlkes; D P McDonnell
Journal:  Endocrinology       Date:  1999-12       Impact factor: 4.736

3.  Peptide antagonists of the human estrogen receptor.

Authors:  J D Norris; L A Paige; D J Christensen; C Y Chang; M R Huacani; D Fan; P T Hamilton; D M Fowlkes; D P McDonnell
Journal:  Science       Date:  1999-07-30       Impact factor: 47.728

4.  Randomized trial of diethylstilbestrol vs. tamoxifen in postmenopausal women with metastatic breast cancer. An updated analysis.

Authors:  P P Peethambaram; J N Ingle; V J Suman; L C Hartmann; C L Loprinzi
Journal:  Breast Cancer Res Treat       Date:  1999-03       Impact factor: 4.872

5.  Alpelisib for PIK3CA-Mutated, Hormone Receptor-Positive Advanced Breast Cancer.

Authors:  Fabrice André; Eva Ciruelos; Gabor Rubovszky; Mario Campone; Sibylle Loibl; Hope S Rugo; Hiroji Iwata; Pierfranco Conte; Ingrid A Mayer; Bella Kaufman; Toshinari Yamashita; Yen-Shen Lu; Kenichi Inoue; Masato Takahashi; Zsuzsanna Pápai; Anne-Sophie Longin; David Mills; Celine Wilke; Samit Hirawat; Dejan Juric
Journal:  N Engl J Med       Date:  2019-05-16       Impact factor: 91.245

6.  The microenvironment matters: estrogen deficiency fuels cancer bone metastases.

Authors:  Laura E Wright; Theresa A Guise
Journal:  Clin Cancer Res       Date:  2014-05-06       Impact factor: 12.531

7.  Investigation of a new pure antiestrogen (ICI 182780) in women with primary breast cancer.

Authors:  D J DeFriend; A Howell; R I Nicholson; E Anderson; M Dowsett; R E Mansel; R W Blamey; N J Bundred; J F Robertson; C Saunders
Journal:  Cancer Res       Date:  1994-01-15       Impact factor: 12.701

8.  Activity of fulvestrant in HER2-overexpressing advanced breast cancer.

Authors:  J F R Robertson; G G Steger; P Neven; S Barni; F Gieseking; F Nolè; K I Pritchard; F P O'Malley; S D Simon; B Kaufman; L Petruzelka
Journal:  Ann Oncol       Date:  2009-10-29       Impact factor: 32.976

9.  Analysis of estrogen receptor function in vitro reveals three distinct classes of antiestrogens.

Authors:  D P McDonnell; D L Clemm; T Hermann; M E Goldman; J W Pike
Journal:  Mol Endocrinol       Date:  1995-06

10.  Phase I Study of Elacestrant (RAD1901), a Novel Selective Estrogen Receptor Degrader, in ER-Positive, HER2-Negative Advanced Breast Cancer.

Authors:  Aditya Bardia; Virginia Kaklamani; Sharon Wilks; Amy Weise; Donald Richards; Wael Harb; Cynthia Osborne; Robert Wesolowski; Meghan Karuturi; Paul Conkling; Rebecca G Bagley; Yamei Wang; Maureen G Conlan; Peter Kabos
Journal:  J Clin Oncol       Date:  2021-01-29       Impact factor: 44.544
View more
  3 in total

1.  Inhibition of estrogen signaling in myeloid cells increases tumor immunity in melanoma.

Authors:  Binita Chakraborty; Jovita Byemerwa; Jonathan Shepherd; Corinne N Haines; Robert Baldi; Weida Gong; Wen Liu; Debarati Mukherjee; Sandeep Artham; Felicia Lim; Yeeun Bae; Olivia Brueckner; Kendall Tavares; Suzanne E Wardell; Brent A Hanks; Charles M Perou; Ching-Yi Chang; Donald P McDonnell
Journal:  J Clin Invest       Date:  2021-12-01       Impact factor: 14.808

2.  The Liver X Receptor Is Selectively Modulated to Differentially Alter Female Mammary Metastasis-associated Myeloid Cells.

Authors:  Liqian Ma; Hashni Epa Vidana Gamage; Srishti Tiwari; Chaeyeon Han; Madeline A Henn; Natalia Krawczynska; Payam Dibaeinia; Graeme J Koelwyn; Anasuya Das Gupta; Rafael Ovidio Bautista Rivas; Chris L Wright; Fangxiu Xu; Kathryn J Moore; Saurabh Sinha; Erik R Nelson
Journal:  Endocrinology       Date:  2022-07-01       Impact factor: 5.051

Review 3.  Tamoxifen Twists Again: On and Off-Targets in Macrophages and Infections.

Authors:  Chiara Sfogliarini; Giovanna Pepe; Arianna Dolce; Sara Della Torre; Maria Candida Cesta; Marcello Allegretti; Massimo Locati; Elisabetta Vegeto
Journal:  Front Pharmacol       Date:  2022-03-30       Impact factor: 5.810
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.